Alida Biosciences Secures Series A Funding


Exciting News for Epigenomic Research

Alida Biosciences, a leader in epigenomic research tools, is thrilled to announce the successful closing of a $7.5 million Series A funding round. This round was led by Genoa Ventures, along with FusionX Ventures and Vertical Venture Partners. In addition to this funding, AlidaBio has secured two ongoing SBIR grants totaling $4 million from The National Human Genome Research Institute. 

Furthermore, AlidaBio is excited to introduce the Early Access launch of two groundbreaking products: the EpiPlex™ RNA Library Prep Kit and the EpiScout™ Analysis Suite. These products offer a comprehensive solution for multiplexed epitranscriptomic analysis of clinical research RNA samples with limited input, providing unmatched sensitivity and accuracy.


More Information : https://www.techdogs.com/tech-news/pr-newswire/alida-biosciences-announces-series-a-funding-and-early-access-launch-of-innovative-products-for-epitranscriptomic-research

Comments

Popular posts from this blog

Aon Unveils $350M Program for Ukraine Recovery

TECNO CAMON 20 Premier 5G and PHANTOM V Flip 5G Secure German Design Awards 2024

Lion Energy Unveils 10W Solar Panel for Portable Power